In addition, $40.0 million of cash was used for the repurchase of outstanding common stock in the first quarter of fiscal 2023.Days sales outstanding is calculated by dividing ending accounts receivable by revenue per day for a given quarter.In addition, $40.0 million of cash was used for the repurchase of outstanding common stock in the first quarter of fiscal 2023.The decrease was primarily due to cash used for the voluntary prepayment of the Term Loan Facility, including the outstanding principal balance of $350.0 million, and all accrued, but unpaid interest outstanding of $3.0 million.In addition, $7.0 million in cash was used for taxes related to net share settlement of equity awards.Revenues outside of the United States represented 46.4% of total net revenues for the three months ended December 31, 2022, compared to 44.5% for the same period in the prior year.Net product revenues remained relatively flat for the three months ended December 31, 2022, from the comparable period in the prior year.Sales and marketing expenses included stock-based compensation expense of $25.7 million for the three months ended December 31, 2022, compared to $26.8 million for the same period in the prior year.For the three months ended December 31, 2022, personnel costs increased $11.8 million from the comparable period in the prior year due to growth in research and development headcount.For the three months ended December 31, 2022, personnel costs increased $4.7 million, from the comparable period in the prior year due to growth in general and administrative headcount.In addition, interest income from our investments increased $3.0 million for the three months ended December 31, 2022 compared to the same period in the prior year.Cash provided by operating activities for the first quarter of fiscal 2023 increased from the comparable period in the prior year primarily due to an increase in cash received from customers, which partially offset strong billings for the quarter and an increase in the balance of accounts receivable.Cash provided by investing activities was $61.9 million for the three months ended December 31, 2022, compared to cash used in investing activities of $42.0 million for the same period in the prior year.Cash used in financing activities was $374.9 million for the three months ended December 31, 2022, compared to cash used in financing activities of $116.0 million for the same period in the prior year.